These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9181558)

  • 1. FDA and Pharmanex clash over dietary supplement.
    Nat Biotechnol; 1997 Jun; 15(6):489. PubMed ID: 9181558
    [No Abstract]   [Full Text] [Related]  

  • 2. Journal supplements, libraries, and the FDA.
    Caelleigh AS
    Bull Med Libr Assoc; 1993 Apr; 81(2):237-9. PubMed ID: 8472012
    [No Abstract]   [Full Text] [Related]  

  • 3. Herbal medicine.
    Wollschlaeger BA
    N Engl J Med; 2003 Apr; 348(15):1498-501; author reply 1498-501. PubMed ID: 12691064
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments about vitamins, nutraceuticals, and dietary enzymes.
    Henderson TR
    J Am Vet Med Assoc; 1995 Jul; 207(1):31. PubMed ID: 7601686
    [No Abstract]   [Full Text] [Related]  

  • 5. Asian medicine. The new face of traditional Chinese medicine.
    Normile D
    Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
    [No Abstract]   [Full Text] [Related]  

  • 6. Truth in advertising: FDA approval and the physician's responsibility.
    Knapp RM
    Anesthesiology; 1992 Mar; 76(3):477-8. PubMed ID: 1539866
    [No Abstract]   [Full Text] [Related]  

  • 7. Truth in advertising.
    Carroll-Johnson RM
    Oncol Nurs Forum; 2001 Apr; 28(3):435. PubMed ID: 11338748
    [No Abstract]   [Full Text] [Related]  

  • 8. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA acknowledges TCM belonging to whole medical systems.
    Cong WH; Chen KJ
    Chin J Integr Med; 2007 Jun; 13(2):83-4. PubMed ID: 17609901
    [No Abstract]   [Full Text] [Related]  

  • 10. Billion-dollar market blossoms as botanicals take root.
    Glaser V
    Nat Biotechnol; 1999 Jan; 17(1):17-8. PubMed ID: 9920256
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA says statin cannot be sold over the counter.
    Gottlieb S
    BMJ; 2000 Jul; 321(7255):196. PubMed ID: 10903643
    [No Abstract]   [Full Text] [Related]  

  • 12. The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
    Kesselheim AS; Fischer MA; Avorn J
    Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 16. Maine law requires drug companies to provide clinical trial data.
    Appell D
    J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043
    [No Abstract]   [Full Text] [Related]  

  • 17. Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr.
    McClellan MB
    FDA Consum; 2003; 37(2):12-7. PubMed ID: 12715764
    [No Abstract]   [Full Text] [Related]  

  • 18. Capitol Hill panelists want FDA intervention in DTC drug advertising.
    Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177
    [No Abstract]   [Full Text] [Related]  

  • 19. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.